New JMCP Article on International Reference Pricing Assesses Global Models

Drs. Leah Rand and Aaron Kesselheim recently published an article in the Journal of Managed Care and Specialty Pharmacy (JMCP) on using international reference pricing (IRP) to reduce prescription drug costs in the US. The authors discuss models used throughout the world, noting that a reliance on a single country’s drug prices could lead to undue price sensitivity.

The authors remark, “The future of IRP under the Biden administration and current Congress is uncertain. Learning from the example of its comparator countries, if the United States adopts an IRP policy, it should be one that uses IRP to anchor price negotiations and complements it with other reimbursement strategies, such as value assessments.” Read more here.

(Source: Rand and Kesselheim, 8/21)